Continuous hyperfractionated accelerated radiotherapy (CHART) using volumetric modulated arc therapy (VMAT) for locally advanced non-small cell lung cancer (NSCLC) - the clinical experience

被引：1
|
作者：
Shrimali, R. [1 ]
Sen, P. [1 ]
Arunsingh, M. [1 ]
Mahata, A. [2 ]
Mallick, I. [1 ]
Prasath, S. [2 ]
Achari, R. [1 ]
Chatterjee, S. [1 ]
机构：
[1] Tata Med Ctr, Radiat Oncol, Kolkata, India
[2] Tata Med Ctr, Kolkata, India
来源：
LUNG CANCER | 2016年 / 91卷
关键词：
D O I：
10.1016/S0169-5002(16)30138-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [1] 10 years of CHART (continuous hyperfractionated accelerated radiotherapy) for non-small cell lung cancer (NSCLC) at NCCC
    Pickles, R. L.
    Iqbal, S.
    Mulvenna, P.
    Mcmenemin, R.
    Kelly, E.
    Atherton, P.
    Turnbull, H.
    Simmons, T.
    Bradshaw, A.
    Mackenzie, L.
    Raven, E.
    LUNG CANCER, 2016, 91 : S50 - S50
  • [2] Treatment with continuous, hyperfractionated, accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC): experience from two UK centres
    Lester, J. E.
    Das, T.
    Esler, C.
    Branagan, J.
    Hatton, M. Q.
    LUNG CANCER, 2011, 71 : S37 - S38
  • [3] Continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC) in patients age 80 and above
    Iqbal, M. S.
    Hassani, A.
    Kelly, E.
    Veeratterapillay, J.
    Mackenzie, L.
    Pickles, R.
    LUNG CANCER, 2018, 115 : S71 - S71
  • [4] Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres
    Sanganalmath, P.
    Lester, J. E.
    Bradshaw, A. G.
    Das, T.
    Esler, C.
    Roy, A. E. F.
    Toy, E.
    Lester, J. F.
    Button, M.
    Wilson, P.
    Comins, C.
    Atherton, P.
    Pickles, R.
    Foweraker, K.
    Walker, G. A.
    Keni, M.
    Hatton, M. Q.
    CLINICAL ONCOLOGY, 2018, 30 (03) : 144 - 150
  • [5] Sequential chemotherapy and continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC): experience from nine UK centres
    Bradshaw, A. G.
    Lester, J. E.
    Das, T.
    Esler, C.
    Branagan, J.
    Roy, A. E. F.
    Toy, E. W.
    Alip, A.
    Lester, J. F.
    Williams, R.
    Kinsman, J.
    Comins, C.
    Atherton, P.
    Knox, C.
    Morgan, S.
    Walker, G. A.
    Hatton, M. Q.
    LUNG CANCER, 2014, 83 : S54 - S54
  • [6] Continuous hyperfractionated accelerated radiotherapy in non-small cell lung cancer
    Ivanova, Irina N.
    Gulidov, Igor A.
    Kudrjavtsev, Dmitry, V
    Zolotkov, Alexey G.
    Kursova, Larisa, V
    Ragulin, Yury A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S955 - S955
  • [7] Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer
    Zwitter, Mayaz
    Kovac, Vijem
    Smrdel, Uros
    Strojan, Primoz
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (07) : 662 - 666
  • [8] Treatment of Non-small Cell Lung Cancer (NSCLC) Using Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART): the Weston Park Hospital Experience 2005-2010
    Lester, J. E.
    Das, T.
    Din, O. S.
    Hatton, M. Q.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S43 - S44
  • [9] Prospective data of continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC) in North East cancer centre
    McFetrich, C.
    Pickles, R.
    Mulvenna, P.
    McMenemin, R.
    Atherton, P.
    McDonald, F.
    Iqbal, M. S.
    Richardson, S.
    Aitken, N.
    LUNG CANCER, 2013, 79 : S54 - S54
  • [10] Pattern of recurrence after continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer
    Din, O.
    Cameron, A.
    Lester, J.
    Moore, B.
    Ironside, J.
    Warnock, J.
    Erridge, S.
    Gee, A.
    Falk, S.
    Klinsman, J.
    Morgan, S.
    Worvill, J.
    Hatton, M.
    LUNG CANCER, 2007, 57 : S11 - S11
12345